{"transactions":[{"id":3003269,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-10-21T00:25:27.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on October 19, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on October 19, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on October 19, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-10-19","expiration_date":"2020-10-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001593968-20-002079","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002079/primary_01.xml","form_type":"4"}},{"id":3003268,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-21T00:25:27.000Z","date":"2020-10-19","kind":"tax_withholding","acquired":false,"shares":2479,"price":10.09,"value":25013.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":17053,"source":{"system":"sec-edgar","filing":"0001593968-20-002079","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002079/primary_01.xml","form_type":"4"}},{"id":3003267,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-21T00:25:27.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":5000,"price":10.09,"value":50450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":19532,"source":{"system":"sec-edgar","filing":"0001593968-20-002079","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002079/primary_01.xml","form_type":"4"}},{"id":3075746,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2020-07-28T00:04:55.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":64173,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64173,"derivative":{"exercise_price":9.4,"exercise_date":"2021-07-23","expiration_date":"2027-07-23","underlying":"Common Stock","underlying_shares":64173},"source":{"system":"sec-edgar","filing":"0001593968-20-001671","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820001671/primary_01.xml","form_type":"4"}},{"id":3075745,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2020-07-28T00:04:55.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":5827,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5827,"derivative":{"exercise_price":9.4,"exercise_date":"2021-07-23","expiration_date":"2027-07-23","underlying":"Common Stock","underlying_shares":5827},"source":{"system":"sec-edgar","filing":"0001593968-20-001671","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820001671/primary_01.xml","form_type":"4"}},{"id":3184294,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2020-04-03T18:17:48.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":5469,"price":9.77,"value":53432.13,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":9.77,"exercise_date":"2021-04-01","expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":5469},"source":{"system":"sec-edgar","filing":"0001628280-20-004582","document":"wf-form4_158593784456621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020004582/wf-form4_158593784456621.xml","form_type":"4"}},{"id":3184293,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Nonqualified Stock Option (Right to Buy)","published_at":"2020-04-03T18:17:48.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":29531,"price":9.77,"value":288517.87,"ownership":{"direct":true},"balance_after":29531,"derivative":{"exercise_price":9.77,"exercise_date":"2021-04-01","expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":29531},"source":{"system":"sec-edgar","filing":"0001628280-20-004582","document":"wf-form4_158593784456621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020004582/wf-form4_158593784456621.xml","form_type":"4"}},{"id":3315535,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2020-01-09T00:50:02.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":9073,"price":10.12,"value":91818.76,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":10.12,"exercise_date":"2021-01-07","expiration_date":"2027-01-07","underlying":"Common Stock","underlying_shares":9073},"source":{"system":"sec-edgar","filing":"0001628280-20-000197","document":"wf-form4_157853098497755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020000197/wf-form4_157853098497755.xml","form_type":"4"}},{"id":3315534,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":145859,"kind":"person","name":"McLaughlin Brian F","position":1,"cik":"0001790969","reported_name":"McLaughlin Brian F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Nonqualified Stock Option (Right to Buy)","published_at":"2020-01-09T00:50:02.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":15927,"price":10.12,"value":161181.24,"ownership":{"direct":true},"balance_after":15927,"derivative":{"exercise_price":10.12,"exercise_date":"2021-01-07","expiration_date":"2027-01-07","underlying":"Common Stock","underlying_shares":15927},"source":{"system":"sec-edgar","filing":"0001628280-20-000197","document":"wf-form4_157853098497755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020000197/wf-form4_157853098497755.xml","form_type":"4"}}]}